AAAAAA

   
Results: 1-12 |
Results: 12
Ziprasidone: Pharmacological and clinical profile of the newest atypical antipsychotic
Authors: Rivas-Vazquez, RA
Citation: Ra. Rivas-vazquez, Ziprasidone: Pharmacological and clinical profile of the newest atypical antipsychotic, PROF PSYCH, 32(6), 2001, pp. 662-665
Understanding drug interactions
Authors: Rivas-Vazquez, RA
Citation: Ra. Rivas-vazquez, Understanding drug interactions, PROF PSYCH, 32(5), 2001, pp. 543-547
Cholinesterase inhibitors: Current pharmacological treatments for Alzheimer's disease
Authors: Rivas-Vazquez, RA
Citation: Ra. Rivas-vazquez, Cholinesterase inhibitors: Current pharmacological treatments for Alzheimer's disease, PROF PSYCH, 32(4), 2001, pp. 433-436
St. John's wort (Hypericum perforatum): Practical considerations based on the evidence
Authors: Rivas-Vazquez, RA
Citation: Ra. Rivas-vazquez, St. John's wort (Hypericum perforatum): Practical considerations based on the evidence, PROF PSYCH, 32(3), 2001, pp. 329-332
A brief reminder about documenting the psychological consultation
Authors: Rivas-Vazquez, RA Blais, MA Rey, GJ Rivas-Vazquez, AA
Citation: Ra. Rivas-vazquez et al., A brief reminder about documenting the psychological consultation, PROF PSYCH, 32(2), 2001, pp. 194-199
Reboxetine: Refocusing on the role of norepinephrine in the treatment of depression
Authors: Rivas-Vazquez, RA
Citation: Ra. Rivas-vazquez, Reboxetine: Refocusing on the role of norepinephrine in the treatment of depression, PROF PSYCH, 32(2), 2001, pp. 211-214
Antidepressants as first-line agents in the current pharmacotherapy of anxiety disorders
Authors: Rivas-Vazquez, RA
Citation: Ra. Rivas-vazquez, Antidepressants as first-line agents in the current pharmacotherapy of anxiety disorders, PROF PSYCH, 32(1), 2001, pp. 101-104
SSRI discontinuation and buspirone
Authors: Carrazana, EJ Rivas-Vazquez, RA Rey, JA Rey, GJ
Citation: Ej. Carrazana et al., SSRI discontinuation and buspirone, AM J PSYCHI, 158(6), 2001, pp. 966-967
Alzheimer's disease: Pharmacological treatment and management
Authors: Rivas-Vazquez, RA Carrazana, EJ Rey, GJ Blais, MA Racher, DA
Citation: Ra. Rivas-vazquez et al., Alzheimer's disease: Pharmacological treatment and management, CLIN NEURPS, 14(1), 2000, pp. 93-109
Atypical antipsychotic medications: Pharmacological profiles and psychological implications
Authors: Rivas-Vazquez, RA Blais, MA Rey, GJ Rivas-Vazquez, AA
Citation: Ra. Rivas-vazquez et al., Atypical antipsychotic medications: Pharmacological profiles and psychological implications, PROF PSYCH, 31(6), 2000, pp. 628-640
Sexual dysfunction associated with antidepressant treatment
Authors: Rivas-Vazquez, RA Blais, MA Rey, GJ Rivas-Vazquez, AA
Citation: Ra. Rivas-vazquez et al., Sexual dysfunction associated with antidepressant treatment, PROF PSYCH, 31(6), 2000, pp. 641-651
Selective serotonin reuptake inhibitor discontinuation syndrome: Understanding, recognition, and management for psychologists
Authors: Rivas-Vazquez, RA Johnson, SL Blais, MA Rey, GJ
Citation: Ra. Rivas-vazquez et al., Selective serotonin reuptake inhibitor discontinuation syndrome: Understanding, recognition, and management for psychologists, PROF PSYCH, 30(5), 1999, pp. 464-469
Risultati: 1-12 |